Research center

Overview

Innovative Positron Emission Tomography (PET) tracers offer attractive opportunities for molecular imaging in the early diagnosis, staging, and guidance of treatment. With an ever increasing demand of efficacious care as well as a growing global awareness of healthcare efficiency and costs, improved diagnostic tools offer a unique opportunity to determine the right therapy at the right dose to the individual patient.

Piramal Healthcare, Imaging Division is developing a product portfolio of innovative molecular imaging probes that address major clinical needs in neurology, oncology, and cardiology.